- Home
- YAAS vs APLT Comparison
YAAS vs APLT Comparison
Compare YAAS & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YAAS
- APLT
- Stock Information
- Founded
- YAAS 2018
- APLT 2016
- Country
- YAAS China
- APLT United States
- Employees
- YAAS N/A
- APLT N/A
- Industry
- YAAS Computer Software: Prepackaged Software
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- YAAS Technology
- APLT Health Care
- Exchange
- YAAS Nasdaq
- APLT Nasdaq
- Market Cap
- YAAS 59.0M
- APLT 69.0M
- IPO Year
- YAAS 2024
- APLT 2019
- Fundamental
- Price
- YAAS $0.32
- APLT $0.51
- Analyst Decision
- YAAS
- APLT Buy
- Analyst Count
- YAAS 0
- APLT 6
- Target Price
- YAAS N/A
- APLT $6.10
- AVG Volume (30 Days)
- YAAS 340.1K
- APLT 826.0K
- Earning Date
- YAAS 07-14-2025
- APLT 08-13-2025
- Dividend Yield
- YAAS N/A
- APLT N/A
- EPS Growth
- YAAS N/A
- APLT N/A
- EPS
- YAAS N/A
- APLT N/A
- Revenue
- YAAS $581,862.00
- APLT $121,000.00
- Revenue This Year
- YAAS N/A
- APLT N/A
- Revenue Next Year
- YAAS N/A
- APLT $5,931.24
- P/E Ratio
- YAAS N/A
- APLT N/A
- Revenue Growth
- YAAS N/A
- APLT N/A
- 52 Week Low
- YAAS $0.30
- APLT $0.30
- 52 Week High
- YAAS $7.00
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- YAAS 37.15
- APLT 56.97
- Support Level
- YAAS $0.30
- APLT $0.48
- Resistance Level
- YAAS $0.35
- APLT $0.53
- Average True Range (ATR)
- YAAS 0.03
- APLT 0.04
- MACD
- YAAS 0.03
- APLT -0.00
- Stochastic Oscillator
- YAAS 22.86
- APLT 80.00
About YAAS Youxin Technology Ltd Class A Ordinary shares
Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.